AI/ML Innovations Engages Frontier Flex Marketing for Market Awareness and Grants Stock Options

Rhea-AI Summary

AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) has announced a marketing services agreement with Frontier Flex Marketing Group to enhance public exposure over 12 months, compensating Frontier $96,000. The company has also issued 1,000,000 stock options to management at an exercise price of $0.20 for five years, pending regulatory approvals. AI/ML Innovations focuses on artificial intelligence and machine learning within digital health, with significant stakes in Health Gauge (100% ownership), Tech2Heal (22% potential ownership), and AI Rx Inc. (70% ownership). The company aims to advance transformative healthcare solutions.

Positive

• Engaged Frontier Flex Marketing Group to enhance market awareness.
• Issued 1,000,000 stock options to management, promoting retention and alignment with shareholder interests.
• Focus on AI and ML in digital health offers growth potential.

Negative

• None.

TORONTO, ON / ACCESSWIRE / March 22, 2023 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, reports that it has engaged Frontier Flex Marketing Group ("Frontier") in a marketing services agreement to facilitate media campaigns. Specifically, Frontier will provide public exposure through multiple mediums, press release distribution, corporate development, and dedicated client leads. The contract with Frontier is for 12 months, with compensation totaling $96,000.

Additionally, the Company has issued a total of 1,000,000 stock options pursuant to its incentive stock option plan (the "Plan") to members of management. Each option entitles the holder to subscribe for one common share of the Company for $0.20. The options have an exercise period of 5 years, and are subject to requisite regulatory approvals and requirements, and the terms of the Plan.

About AI/ML Innovations Inc.

AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (100% owned by AIML), Tech2Heal (up to 22% ownership rights, with 9.44% currently owned), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".

On behalf of the Board of Directors

Tim Daniels, Executive Chairman

For more information about AI/ML Innovations:
For detailed information please see AI/ML's website at https://aiml-innovations.com/
The Company's filed documents at www.sedar.com.
Official YouTube Channel: https://www.youtube.com/channel/UCCfOj2P_Fu3TOK6Jl1G9vEQ
For further information: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

For AI/ML Innovations Investors

Certain statements made in this press release that are not based on historical information are forward-looking statements that involve substantial known and unknown risks and uncertainties. This press release contains express or implied forward-looking statements relating to, among other things, AI/ML Innovations' expectations concerning management's plans, objectives and strategies, including strategies for defending the Company's intellectual property. These statements are neither promises nor guarantees but are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. AI/ML Innovations Inc. undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise except as expressly required by applicable securities law. Further information regarding the uncertainties and risks can be found in the disclosure documents filed by AI/ML with the securities regulatory authorities, available at www.sedar.com.

SOURCE: AI/ML Innovations Inc.

View source version on accesswire.com:
https://www.accesswire.com/745259/AIML-Innovations-Engages-Frontier-Flex-Marketing-for-Market-Awareness-and-Grants-Stock-Options

FAQ

What is the significance of the marketing agreement with Frontier Flex for AIMLF?

The marketing agreement with Frontier Flex aims to increase public exposure and corporate development for AIMLF, which could enhance investor interest.

What are the details of the stock options granted by AIML?

AIML granted 1,000,000 stock options to management at an exercise price of $0.20 each, with a five-year exercise period, subject to regulatory approvals.

How does AIML plan to utilize AI and ML technologies?

AIML plans to leverage AI and ML technologies to invest in digital health companies, enabling transformative healthcare solutions.

What is AIMLF's focus in the digital health sector?

AIMLF focuses on investing in companies that apply AI and ML for better healthcare management and support delivery.